ArticlePeerJ2025
Application of an interpretable machine learning model based on optimal feature selection for predicting triple-vessel coronary disease: a multicenter retrospective study.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Customer churn prediction in privacy-preserving HashCode-based security abstractions.Scientific reports · 2026Article
- Comparative Analysis of Logistic Regression and Machine Learning Algorithms for Predicting De Novo Stress Urinary Incontinence or Symptomatic Worsening Following Pelvic Floor Reconstruction: A Multicenter Study.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Objective: This study aimed to evaluate the predictive value of the remnant cholesterol-inflammatory index (RCII) in assessing the risk of triple-vessel disease (TVD), and to construct a comparative framework of predictive models using six machine learning algorithms based on RCII and other clinical features for identifying high-risk individuals. Methods: In this retrospective multicenter study, we enrolled 2,911 patients who underwent coronary angiography between January 1, 2024, and December 31, 2024, at two tertiary hospitals. Clinical and laboratory data were collected. Feature selection was performed using both Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariate logistic regression. Six machine learning (ML) algorithms were trained for risk prediction, with multilayer perceptron (MLP) selected as the optimal model for the final feature set. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), positive predictive value (PPV), and F1 score. SHapley Additive exPlanations (SHAP) analysis was applied to interpret feature contributions and interactions. Results: A total of 16 features were selected by LASSO regression, while multivariate logistic regression identified six independent predictors. Four overlapping features-gender, age, aspartate aminotransferase (AST), and RCII-were used for ML model development. Among the six models, the MLP demonstrated the best overall performance on the test set. SHAP analysis revealed that RCII, age, AST, and gender were the top contributors to model prediction, with RCII showing notable interaction effects with other variables, highlighting its both independent and synergistic role in TVD risk stratification. Conclusion: RCII, as a composite biomarker integrating lipid metabolism and chronic inflammation, demonstrates strong predictive utility in identifying individuals at high risk for triple-vessel coronary disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.